AI/Q Fund

As director of the AI/Q Fund at Connecticut Innovations, Gwen Cheni is responsible for the strategic direction of the fund and the deployment of capital of the $50M fund. Gwen, the cofounder of a stealth startup, was previously a partner on the investment team at Khosla Ventures and a partner at IndieBio/SOSV covering bio and AI. Prior to IndieBio, she was the founder and managing partner of Galapagos Ventures, an early-stage venture fund focused on the intersection of biology and AI/ML. She was also a director at StudioX (machine learning venture studio funded by Shell and Boston Consulting Group) and a venture partner at Fusion Fund (an early-stage fund focused on AI/ML, robotics and devices). Gwen was on the board of advisors at Singularity University Ventures, an impact-focused accelerator, and helped launch their first batch of startups in the Nordics. Gwen spent 18 years on Wall Street investing in public equities. After working at Goldman Sachs and JPMorgan, she was promoted to portfolio manager at a $300 million innovation-themed hedge fund. Gwen is bilingual in computer science programming languages and wet lab research protocols. On the computer science side, she received her bachelor’s degree in economics (math track) with a minor in computer science electrical engineering from Yale University. One of her four MBA concentrations from the University of Chicago was econometrics/statistical learning. She graduated from University of Chicago in two years while working full-time as an associate at JPMorgan. On the wet lab biology side, Gwen spent two years at UCSF researching immunotherapy for glioblastomas. She sits on the advisory board of the Yale University School of Medicine.